A COST-EFFECTIVENESS MODEL OF BAZEDOXIFENE VS. RALOXIFENE FOR THE PREVENTION OF FRACTURES IN SPANISH POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Darba, Josep [1 ]
Perez-Alvarez, Nuria [2 ]
Kaskens, Lisette [2 ]
Racketa, Jill [3 ]
Rejas, Javier [4 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
[2] BCN Hlth Econ & Outcomes Res, Barcelona, Spain
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Hlth Econ & Outcomes Res Dept, Madrid, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF BAZEDOXIFENE VS. RALOXIFENE AMONG SUBGROUPS OF POSTMENOPAUSAL WOMEN WITH DIFFERENT FRACTURE RISKS ASSESSED BY FRAX®
    Luo, Xuemei
    Svedbom, Axel
    Kim, Kun
    Sutradhar, Santosh
    Kanis, John A.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S349 - S350
  • [2] COST-EFFECTIVENESS OF BAZEDOXIFENE COMPARED WITH RALOXIFENE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Bruyere, Olivier
    Reginster, Jean-Yves
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S312 - S313
  • [3] Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Reginster, Jean-Yves
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (04) : 807 - 815
  • [4] Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
    Darba, Josep
    Perez-Alvarez, Nuria
    Kaskens, Lisette
    Holgado-Perez, Susana
    Racketa, Jill
    Rejas, Javier
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 327 - 336
  • [5] COST-EFFECTIVENESS OF BAZEDOXIFENE VS. RALOXIFENE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS USING FRAX® IN EUROPEAN COUNTRIES
    Svedbom, Axel
    Luo, Xuemei
    Kanis, John
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S65 - S65
  • [6] Cost-Effectiveness of Bazedoxifene Compared with Raloxifene in the Treatment of Postmenopausal Osteoporotic Women.
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Reginster, J. -Y.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S834 - S834
  • [7] Cost-effectiveness of raloxifene to prevent osteoporotic fractures among postmenopausal women in Australia
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Grainger, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S28 - S28
  • [8] Cost-effectiveness of raloxifene for the prevention of osteoporotic fractures in Australia
    Davey, PJ
    Lees, M
    Graham-Clarke, P
    VALUE IN HEALTH, 2003, 6 (03) : 224 - 224
  • [9] A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden
    Michael Willis
    Knut Ödegaard
    Ulf Persson
    Johan Hedbrant
    Dan Mellström
    Mats Hammar
    Clinical Drug Investigation, 2001, 21 : 115 - 127
  • [10] A cost-effectiveness model of tibolone as treatment for the prevention of osteoporotic fractures in postmenopausal women in Sweden
    Willis, M
    Ödegaard, K
    Persson, U
    Hedbrant, J
    Mellström, D
    Hammar, M
    CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 115 - 127
12345